Cargando…
Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
BACKGROUND: There are inconsistent conclusions about whether CYP2C19 variants could affect H. pylori eradication rate in patients treated with the proton pump inhibitor (PPI)-based therapy. We therefore performed a meta-analysis of randomized clinical trials (RCTs) to re-evaluate the impact of CYP2C...
Autores principales: | Tang, Hui-Lin, Li, Yan, Hu, Yong-Fang, Xie, Hong-Guang, Zhai, Suo-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639978/ https://www.ncbi.nlm.nih.gov/pubmed/23646118 http://dx.doi.org/10.1371/journal.pone.0062162 |
Ejemplares similares
-
Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016) -
Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori
por: Lin, Yun-An, et al.
Publicado: (2017) -
Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016) -
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Tanabe, Hiroki, et al.
Publicado: (2018) -
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)